When processed within the tumor cell and presented by the major histocompatibility complex (MHC) molecules, neoantigens can be captured and recognized by specific T cell receptors (TCR) via TCR/peptide/MHC interactions [18] (Figure 1). This evidence concerns the gene HLA-C and neoplasm.